Troglitazone in Treating Patients With Liposarcoma
Status:
Completed
Trial end date:
2000-01-01
Target enrollment:
Participant gender:
Summary
Troglitazone may help liposarcoma cells develop into normal cells. This was a single arm,
open-label study with a two-stage design to evaluate troglitazone in patients with
liposarcoma stratified by histologic subtype.